Additional thoughts on the new treatment Kybella

9Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

With the recent approval of Kythera Biopharmaceuticals (Westlake Village, California) submental fat injectable treatment Kybella, there comes a lot of excitement-but, also a bit of concern. The idea of having a nonsurgical, nonliposuction treatment for people who have a double chin is certainly exciting. The hope has been that this new treatment will provide opportunities for the many people out there who are focused on the appearance of their submental fullness to have access to a safe, affordable, and reliable treatment.With the approval of this product, there are several misconceptions that the authors herein discuss.

Cite

CITATION STYLE

APA

Cohen, J. L., Chen, D. L. K., Green, J. B., & Joseph, J. H. (2015). Additional thoughts on the new treatment Kybella. Seminars in Cutaneous Medicine and Surgery, 34(3), 138–139. https://doi.org/10.12788/j.sder.2015.0175

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free